BG60317B2 - Инденоиндолови съединения - Google Patents

Инденоиндолови съединения Download PDF

Info

Publication number: BG60317B2
Authority: BG; Bulgaria
Prior art keywords: cis; tetrahydro; group; formula; indole
Prior art date: 1989-06-22

Application number

BG095667A

Other languages

Bulgarian (bg)

English (en)

Inventor

Malcolm Sainsbury

Howard Shertzer

Original Assignee

University Of Bath

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-06-22

Filing date

1991-12-20

Publication date

1994-07-25

1991-12-20 Application filed by University Of Bath filed Critical University Of Bath

1994-07-25 Publication of BG60317B2 publication Critical patent/BG60317B2/bg

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Psychology (AREA)
Indole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

BG095667A 1989-06-22 1991-12-20 Инденоиндолови съединения BG60317B2 (bg)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE8902274A SE8902274D0 (sv)	1989-06-22	1989-06-22	Indenoidole compounds ii
PCT/GB1990/000949 WO1990015799A1 (en)	1989-06-22	1990-06-20	Indenoindole compounds ii

Publications (1)

Publication Number	Publication Date
BG60317B2 true BG60317B2 (bg)	1994-07-25

Family

ID=20376370

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG095667A BG60317B2 (bg)	1989-06-22	1991-12-20	Инденоиндолови съединения

Country Status (34)

Country	Link
EP (1)	EP0409410B1 (de)
JP (1)	JP3064411B2 (de)
KR (1)	KR920702679A (de)
CN (1)	CN1033029C (de)
AT (1)	ATE135688T1 (de)
BG (1)	BG60317B2 (de)
CA (1)	CA2060897A1 (de)
DD (1)	DD297960A5 (de)
DE (1)	DE69025998T2 (de)
DK (1)	DK0409410T3 (de)
DZ (1)	DZ1428A1 (de)
ES (1)	ES2084660T3 (de)
FI (1)	FI100800B (de)
GR (1)	GR3019779T3 (de)
HR (1)	HRP920903B1 (de)
HU (1)	HUT59097A (de)
IE (1)	IE74682B1 (de)
IL (1)	IL94830A (de)
IS (1)	IS3590A7 (de)
LT (1)	LT3675B (de)
LV (1)	LV10253B (de)
MX (1)	MX21244A (de)
MY (1)	MY107311A (de)
NO (1)	NO177932C (de)
NZ (1)	NZ234175A (de)
PL (1)	PL167761B1 (de)
PT (1)	PT94468B (de)
RO (1)	RO111573B1 (de)
RU (1)	RU2104270C1 (de)
SE (1)	SE8902274D0 (de)
SI (1)	SI9011223B (de)
WO (1)	WO1990015799A1 (de)
YU (1)	YU122390A (de)
ZA (1)	ZA904827B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU9301104D0 (en) *	1990-10-16	1993-07-28	Univ Bath	Method for producing tetrahydro-indeno-indole derivatves and pharmaceutical preparatives containing it
JPH0656669A (ja) *	1992-06-11	1994-03-01	Asahi Breweries Ltd	活性酸素消去作用を持つプテリン誘導体製剤
SE9302431D0 (sv) *	1993-07-16	1993-07-16	Ab Astra	Use of indenoindole compounds
AU675141B2 (en) *	1993-07-20	1997-01-23	Adir Et Compagnie	(Thia)cycloalkyl(b)indoles, process for preparing them and pharmaceutical compositions containing them
US6288099B1 (en)	1998-12-04	2001-09-11	American Home Products Corporation	Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
BR9915900A (pt) *	1998-12-04	2001-08-21	American Home Prod	Composto, composição farmacêutica, e, processo para tratar ou inibir distúrbios associados com contração da musculatura lisa.
FR2826009B1 (fr) *	2001-06-13	2003-08-15	Servier Lab	Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1910338B1 (de)	2005-07-14	2010-08-25	Irm, Llc	Heterotetracyclische verbindungen als tpo-mimetica
DE102006047231B4 (de)	2006-10-04	2009-02-12	Hemmerling, Hans-Jörg, Dr.	Substituierte Indeno[1,2-b]indolderivate als neue Hemmstoffe der Protein Kinase CK2 und ihre Verwendung als Tumor Therapeutika, Cytostatika und Diagnostika
EA026149B1 (ru) *	2011-06-16	2017-03-31	Корея Рисерч Инститьют Оф Кемикал Текнолоджи	Производное инданона, его фармацевтически приемлемая соль или оптический изомер, способ его получения и содержащая его фармацевтическая композиция для профилактики или лечения вирусного заболевания
PL3882244T3 (pl)	2012-12-14	2025-06-16	Korea Research Institute Of Chemical Technology	ZWIĄZEK, JEGO FARMACEUTYCZNIE DOPUSZCZALNA SÓL LUB IZOMER OPTYCZNY, SPOSÓB ICH WYTWARZANIA i ZAWIERAJĄCA JE, JAKO SKŁADNIK AKTYWNY, KOMPOZYCJA FARMACEUTYCZNA DO PROFILAKTYKI LUB LECZENIA CHORÓB WIRUSOWYCH
US12286423B2 (en)	2020-04-20	2025-04-29	Novartis Ag	Antiviral 1,3-di-oxo-indene compounds
CA3176727A1 (en)	2020-04-20	2021-10-28	Novartis Ag	Antiviral 1,3-di-oxo-indene compounds

1989
- 1989-06-22 SE SE8902274A patent/SE8902274D0/xx unknown
1990
- 1990-06-13 IS IS3590A patent/IS3590A7/is unknown
- 1990-06-20 RO RO149127A patent/RO111573B1/ro unknown
- 1990-06-20 WO PCT/GB1990/000949 patent/WO1990015799A1/en not_active Ceased
- 1990-06-20 PL PL90285752A patent/PL167761B1/pl unknown
- 1990-06-20 DK DK90306718.9T patent/DK0409410T3/da active
- 1990-06-20 DE DE69025998T patent/DE69025998T2/de not_active Expired - Fee Related
- 1990-06-20 EP EP90306718A patent/EP0409410B1/de not_active Expired - Lifetime
- 1990-06-20 AT AT90306718T patent/ATE135688T1/de active
- 1990-06-20 IE IE224790A patent/IE74682B1/en not_active IP Right Cessation
- 1990-06-20 DZ DZ900114A patent/DZ1428A1/fr active
- 1990-06-20 MX MX21244A patent/MX21244A/es unknown
- 1990-06-20 CA CA002060897A patent/CA2060897A1/en not_active Abandoned
- 1990-06-20 ES ES90306718T patent/ES2084660T3/es not_active Expired - Lifetime
- 1990-06-20 HU HU904825A patent/HUT59097A/hu unknown
- 1990-06-20 RU SU5010937A patent/RU2104270C1/ru active
- 1990-06-20 JP JP2508940A patent/JP3064411B2/ja not_active Expired - Fee Related
- 1990-06-21 NZ NZ234175A patent/NZ234175A/xx unknown
- 1990-06-21 ZA ZA904827A patent/ZA904827B/xx unknown
- 1990-06-21 IL IL9483090A patent/IL94830A/en not_active IP Right Cessation
- 1990-06-21 DD DD90341939A patent/DD297960A5/de not_active IP Right Cessation
- 1990-06-21 MY MYPI90001050A patent/MY107311A/en unknown
- 1990-06-22 CN CN90104933A patent/CN1033029C/zh not_active Expired - Fee Related
- 1990-06-22 YU YU122390A patent/YU122390A/sh unknown
- 1990-06-22 PT PT94468A patent/PT94468B/pt not_active IP Right Cessation
- 1990-06-22 SI SI9011223A patent/SI9011223B/sl unknown
1991
- 1991-12-19 FI FI915999A patent/FI100800B/fi active
- 1991-12-20 BG BG095667A patent/BG60317B2/bg unknown
- 1991-12-20 NO NO915049A patent/NO177932C/no unknown
- 1991-12-23 KR KR1019910701951A patent/KR920702679A/ko not_active Ceased
1992
- 1992-10-02 HR HRP-1223/90A patent/HRP920903B1/xx not_active IP Right Cessation
1993
- 1993-06-14 LV LVP-93-568A patent/LV10253B/xx unknown
- 1993-08-30 LT LTIP912A patent/LT3675B/lt not_active IP Right Cessation
1996
- 1996-04-29 GR GR960401159T patent/GR3019779T3/el unknown

Also Published As

Publication number	Publication date
IE902247A1 (en)	1991-01-16
NZ234175A (en)	1992-12-23
HU904825D0 (en)	1992-03-30
IE902247L (en)	1990-12-22
NO177932C (no)	1995-12-20
YU122390A (sh)	1992-09-07
HRP920903B1 (en)	1998-06-30
IL94830A0 (en)	1991-04-15
RU2104270C1 (ru)	1998-02-10
ATE135688T1 (de)	1996-04-15
DE69025998D1 (de)	1996-04-25
JP3064411B2 (ja)	2000-07-12
MY107311A (en)	1995-11-30
PT94468A (pt)	1991-02-08
IL94830A (en)	1996-07-23
PL167761B1 (pl)	1995-10-31
IE74682B1 (en)	1997-07-30
DZ1428A1 (fr)	2004-09-13
LT3675B (en)	1996-01-25
CN1033029C (zh)	1996-10-16
ZA904827B (en)	1991-04-24
DE69025998T2 (de)	1996-08-08
JPH04505923A (ja)	1992-10-15
NO915049D0 (no)	1991-12-20
PT94468B (pt)	1997-12-31
NO177932B (no)	1995-09-11
AU644084B2 (en)	1993-12-02
EP0409410B1 (de)	1996-03-20
CN1051554A (zh)	1991-05-22
MX21244A (es)	1994-03-31
LV10253A (lv)	1994-10-20
HRP920903A2 (hr)	1994-04-30
FI915999A0 (fi)	1991-12-19
WO1990015799A1 (en)	1990-12-27
SI9011223A (en)	1997-10-31
SI9011223B (sl)	1998-08-31
NO915049L (no)	1992-02-21
FI100800B (fi)	1998-02-27
HUT59097A (en)	1992-04-28
AU5836990A (en)	1991-01-08
LTIP912A (en)	1995-03-27
KR920702679A (ko)	1992-10-06
GR3019779T3 (en)	1996-07-31
IS3590A7 (is)	1990-12-23
SE8902274D0 (sv)	1989-06-22
LV10253B (en)	1995-04-20
DK0409410T3 (da)	1996-04-29
PL285752A1 (en)	1991-03-11
DD297960A5 (de)	1992-01-30
ES2084660T3 (es)	1996-05-16
EP0409410A1 (de)	1991-01-23
RO111573B1 (ro)	1996-11-29
CA2060897A1 (en)	1990-12-23

Publication	Publication Date	Title
KR900003492B1 (ko)	1990-05-21	피페라지닐-헤테로시클릭 화합물
EP0580502B1 (de)	1998-09-02	3-(Hydroxybenzylidenyl)-Indolin-2-one und diese enthaltende Arzneimittel
EP2364298B1 (de)	2016-08-03	Chinolonverbindung und pharmazeutische zusammensetzung
EP0409410B1 (de)	1996-03-20	Indenoindolverbindungen
US5185360A (en)	1993-02-09	Dihydroindenoindole compounds and methods for using the same
EP0527081A1 (de)	1993-02-10	Substituierte 3-Piperazinylalkyl 2,3-Dihydro-4H-1,3-Benzoxazin-4-One, deren Herstellung und Verwendung in Heilkunde
EP0239476B1 (de)	1990-10-24	Pyridoindolderivate, ihre Verwendung als Arzneimittel und diese enthaltende Zubereitungen
US5516788A (en)	1996-05-14	Tetrahydroindenoindole compounds useful in the treatment of conditions associated with free radical formation
AP339A (en)	1994-05-02	Indenoindoles compounds.
EP0433167B1 (de)	1994-03-02	Piperidinderivate, Verfahren zur Herstellung sowie diese enthaltende pharmazeutische Präparate
EP1129097B1 (de)	2003-01-29	Kondensierte pyridazinonverbindungen
AU644084C (en)	1995-01-05	Indenoindole compounds II
EP0449728A1 (de)	1991-10-02	4H-Pyrrolo (1,2-a)thieno(2,3-f)(1,4)diazepinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
HK1156542B (en)	2017-04-28	Quinolone compound and pharmaceutical composition